Preimplantation genetic testing for aneuploidies (PGT-A) is used to increase live birth rates
following in vitro fertilization. The assessment of different PGT-A methods to date has relied …

Preimplantation genetic testing for aneuploidies (PGT-A) is used to increase live birth rates
following in vitro fertilization. The assessment of different PGT-A methods to date has relied …

Study question What is the accuracy of reporting chromosomal mosaicism in the context of
next generation sequencing (NGS)-based preimplantation genetic testing for aneuploidies …

OBJECTIVE Preimplantation genetic testing for aneuploidies (PGT-A) aims to improve
clinical outcomes. However, diagnostic accuracy remains a concern, particularly when …

Introduction Unlike previous technologies that lack the diagnostic performance to reliably
detect mosaicism for preimplantation genetic testing for aneuploidy (PGT-A), next generation …

Background The enhancements to reproductive medicine conferred by Preimplantation
Genetic Testing for Aneuploidy (PGT-A) hinge on the test delivering clinically relevant …

Despite improvements in assisted reproduction techniques (ARTs), live birth rates remain
suboptimal, particularly in women with advanced maternal age (AMA). The leading cause of …

Chromosomal aneuploidy is recognized to be a significant contributing factor in implantation
failure and spontaneous miscarriage Hellani et al.(Reprod Biomed Online 17: 841–847 …

Objective Preimplantation genetic testing for aneuploidies (PGT-A) has been introduced into
clinical practice to improve outcomes. However, diagnostic accuracy remains controversial …

Objective The use of pre-implantation genetic testing for aneuploidy (PGT-A) has been
increasing steadily for the past few years. The policy of most programs is to discard …